Opendata, web and dolomites

OrmoSys

Orthopaedic Modular System for a systematic diagnosis and treatment of foot and related musculoskeletal deformities

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OrmoSys project word cloud

Explore the words cloud of the OrmoSys project. It provides you a very rough idea of what is the project "OrmoSys" about.

expertise    errors    unskilled    diagnosing    meet    insoles    sharply    complete    diagnosis    improperly    patients    orthotic    poor    pressure    orthotics    manufacturer    18bn    standardised    individual    trl7    dynamic    successful    market    operators    life    light    customer    shapes    patient    materials    ict    unacceptable    acquired    postural    aging    consistent    algorithms    sad    demographics    disabling    decline    unaddressed    suffer    treating    lkz    movement    dependent    later    types    feet    points    satisfaction    static    formed    handle    insole    room    ailments    customised    200    000    limited    soles    ormosys    prototype    combining    building    pain    decreased    treatment    foot    modular    introduction    people    price    proven    physical    leads    designed    quality    precisely    acceptable    inevitably    sport    744    musculoskeletal    professionals    powerful    medical    comfort    decreasing    designer    markets    extensive    designing    39    recommends    tests   

Project "OrmoSys" data sheet

The following table provides information about the project.

Coordinator
LANGMEIER FATMIR FETULA 

Organization address
address: WOLFSPOINT 1
city: ROHRDORF
postcode: 83101
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://ormosys.de/
 Total cost 2˙673˙750 €
 EC max contribution 1˙871˙625 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LANGMEIER FATMIR FETULA DE (ROHRDORF) coordinator 1˙871˙625.00

Map

 Project objective

200,000,000. This is the sad number of people in the EU that currently suffer pain due to improperly formed feet and adequate orthotic support. This number is expected to rise sharply in the next years due to increasingly aging demographics and decreased physical activity. An improperly formed foot that is unaddressed by adequate orthotic support inevitably results in disabling musculoskeletal problems later in life. In this light it is unacceptable that currently 2 out of 5 orthotic insoles are improperly designed due to poor diagnosis, design or production. Current systems for designing orthotic soles are static and do not take into account pressure points or dynamic movement of the patient. Furthermore, these systems are highly dependent of the individual technical expertise of the insole designer and manufacturer. This along with the decreasing number of orthotics professionals in Europe leads to a decline in the overall quality and availability of adequate orthotic insoles. Based on the knowledge acquired from extensive diagnosing and treating, LKZ has developed OrmoSys, a complete system for the diagnosis and treatment of foot and postural ailments. Building on standardised tests and powerful algorithms, an ICT-system recommends fully customised orthotic insoles. By combining a limited number of shapes and materials, OrmoSys allows for 39,744 different insole types which precisely address the patients’ problems. Built on proven technical knowledge, this orthotic modular system allows unskilled operators with low experience to develop quality and consistent orthotic insoles, with less room for errors. The goal of the project is to produce the current prototype (TRL7) to meet the identified market requirements, i.e. high product quality and customer satisfaction, easy to handle, acceptable price. This will facilitate the successful introduction of OrmoSys in the identified markets for comfort, sport and medical orthotic insoles, thus addressing an 18bn € market.

 Deliverables

List of deliverables.
Website Websites, patent fillings, videos etc. 2019-07-18 20:00:22
Certified medical claim Documents, reports 2019-07-18 20:00:22
Sample of produced insoles Demonstrators, pilots, prototypes 2019-07-18 20:00:22

Take a look to the deliverables list in detail:  detailed list of OrmoSys deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ORMOSYS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ORMOSYS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More